Phenylbutazone use as an NSAID is restricted because :
It has lower anti-inflammatory efficacy than other NSAIDs
It has potential to cause agranulocytosis
It has weak analgesic action
It alters the protein binding and metabolism of many drugs
It has potential to cause agranulocytosis